Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Casamento Insider Profile
4 Followers
Charles Casamento, Director at Relmada Therapeutics, holds 0.00 shares in Relmada Therapeutics (Ticker: RLMD), holds 2.39K shares in PaxMedica, Inc. (Ticker: PXMD), holds 19.94K shares in Entero Therapeutics (Ticker: ENTO).
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+36.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Casamento holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 18, 2023 - Sep 18, 2024
Return:+95.60%
The most profitable trade made by Charles Casamento
Charles Casamento's Trading History
Relmada Therapeutics
Oct 23, 2024
Director
Uninformative Sell
―
$0.00
Entero Therapeutics
Jan 04, 2024
Director
Uninformative Buy
―
$7.97K
Eton Pharmaceuticals
Aug 12, 2019
Director
Informative Buy
21.35K
$750.13K
PaxMedica, Inc.
Mar 14, 2024
Director
Uninformative Sell
684.48
$248.14
GT Biopharma
―
Director
―
―
Vivus
Apr 22, 2013
―
Uninformative Sell
―
$10.19K
International Stem Cell
Jun 25, 2018
Director
Uninformative Buy
―
$1.30K
List of latest transactions for each holding click on a transaction to see Charles Casamento's performance on stock
You May Also Like
Charles Casamento insider profile FAQ
What is the percentage of profitable transactions made by Charles Casamento?
The percentage of profitable transactions made by Charles Casamento is 80%.
What is the average return per transaction made by Charles Casamento?
The average return per transaction made by Charles Casamento is 36.60%.
What stocks does Charles Casamento hold?
Charles Casamento holds: RLMD, ENTO, ETON, PXMD, GTBP, VVUSQ, ISCO stocks.
What was Charles Casamento’s latest transaction?
Charles Casamento latest transaction was an Uninformative Sell of ―.
What was Charles Casamento's most profitable transaction?
Charles Casamento’s most profitable transaction was an Informative Sell of ENTO stock on September 18, 2023. The return on the trade was 95.60%.
What is Charles Casamento's role in Relmada Therapeutics?
Charles Casamento's role in Relmada Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.